INVEST IN THE CANNABIS INDUSTRY WITH CANNARA

We’re changing the narrative in the industry;
We offer premium cannabis, grown from rare genetics, hand-trimmed then slow cured and sold at disruptively low pricing.
We’ve rapidly emerged as one of Quebec’s fast-growing producers and we’ve got a bright future ahead of us.

Q1 2024 FINANCIAL HIGHLIGHTS:

  • Q1 2024 gross cannabis revenue increased by $15.1 million, from $11.2 million in Q1 2023 to $26.3 million in Q1 2024.

  • Q1 2024 net revenues increased by 89% to $19.5 million compared to the $10.3 million of net revenues generated in Q1 2023.

  • Q1 2024 gross profit before fair value adjustments was $7.9 million, a 98% increase compared to $4 million of gross profit before fair value adjustments generated in Q1 2023.

  • Q1 2024 operating income increased to $3.4 million, a 210% increase compared to the $1.1 million of operating income generated in Q1 2023.

  • Delivered the Company’s eleventh straight quarter of positive Adjusted EBITDA of $5.2 million, a 206% increase compared to the $1.7 million of positive Adjusted EBITDA generated in Q1 2023.

  • Q1 2024 net income of $2.1 million compared to the $2,951 of net income generated in Q1 2023.

  • The Company generated earnings per share of $0.02 in Q1 2024.

  • Posted positive operating cash flows of $400k for Q1 2024, a 233% increase compared to negative operating cash flows of $300k generated in Q1 2023.

  • Free cash flow for Q4 2023 increased to $4.9 million, a 145% increase compared to the free cash flow of $2 million recorded in Q1 2023.

  • The Company has $30.5 million in working capital as of November 30, 2023.
  • To learn more about Cannara, download our deck: